Ergothioneine alleviates osteoporosis via the ROS-MAPK signaling Axis
Bone · 2025-08 · 197 · 117496
DOI: 10.1016/j.bone.2025.117496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2025-08. Verfasst von Zhen Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200072 Shanghai, PR China; School of Clinical Med…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Osteoporosis, Ergothioneine, MAP Kinase Signaling System. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
The accumulation of reactive oxygen species (ROS) within cells regulates the formation and function of osteoclasts, which is crucial therapeutic target for the treatment of osteoporosis. Ergothioneine (EGT) is a rare amino acid with strong antioxidant and anti-inflammatory properties. However, its application on osteoporosis has not been reported. In this study, we investigated the effects of EGT on osteoclastogenesis in vitro and in ovariectomized (OVX) mice. The results revealed that EGT could suppress RANKL-induced podosome belt formation and osteoclast development in vitro, while reducing intracellular ROS levels by upregulating key antioxidant enzymes, including HO-1 and Catalase. EGT was also found to downregulate the expression of critical osteoclast-specific proteins such as Trap, c-Fos, and Ctsk through attenuation of MAPK signaling. The potential of EGT to protect against trabecular bone loss in OVX mice was further demonstrated by micro-CT imaging, possibly by reducing osteoclast numbers shown by histological outcomes. These findings together highlighted the potential value of EGT as a novel tool for treating osteoporosis through its ability to suppress osteoclastogenesis and mitigate the accumulation of intracellular ROS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200072 Shanghai, PR China; School of Clinical Medicine, Jinggangshan University, 343009 Ji'an, Jiangxi, China.
- Department of Stomatology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200072 Shanghai, PR China.
- Department of Stomatology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200072 Shanghai, PR China. Electronic address: shallvv@tongji.edu.cn.
- Department of Stomatology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200072 Shanghai, PR China. Electronic address: hanyi612@tongji.edu.cn.
- Department of Stomatology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200072 Shanghai, PR China; Medical College, Anhui University of Science and Technology, Huainan, China.
- Department of Gastrointestinal Surgery, Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Zitieren
APA
Guo, Z., Huang, Y., Wang, X., Han, Y., Li, A., Qu, Y., Chen, L., Du, M., Zhang, Y., & Xu, Y. (2025). Ergothioneine alleviates osteoporosis via the ROS-MAPK signaling Axis. Bone, 197, 117496. https://doi.org/10.1016/j.bone.2025.117496
Vancouver
Guo Z, Huang Y, Wang X, Han Y, Li A, Qu Y, et al. Ergothioneine alleviates osteoporosis via the ROS-MAPK signaling Axis. Bone. 2025;197:117496. doi:10.1016/j.bone.2025.117496
BibTeX
@article{Guo2025,
author = {Guo, Zhen and Huang, Yiwen and Wang, Xiaowei and Han, Yi and Li, Ang and Qu, Yiyang and Chen, Lin and Du, Meihang and Zhang, Yiming and Xu, Yuanzhi},
title = {Ergothioneine alleviates osteoporosis via the ROS-MAPK signaling Axis},
journal = {Bone},
year = {2025},
volume = {197},
pages = {117496},
doi = {10.1016/j.bone.2025.117496}
}
EUVIMED